Evrysdi

Evrysdi Indications/Uses

Manufacturer:

Roche

Distributor:

DKSH

Marketer:

Roche
Full Prescribing Info
Indications/Uses
Evrysdi is indicated for the treatment of SMA in patients 2 months of age and older, with a clinical diagnosis of type 1, Type 2 or Type 3 SMA or with one to four SMN2 copies.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in